Healthcare Services

Global Visceral Pain Market Expected to Reach $19.6 Billion by 2030 with 5.7% CAGR

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Visceral Pain Market Over The 2026–2030 Period?

The visceral pain market size has experienced significant expansion in recent years. It is projected to increase from $14.82 billion in 2025 to $15.7 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.9%. The market’s past growth is attributable to the rising prevalence of gastrointestinal and pelvic disorders, the expanded use of NSAIDs and calcium channel blockers, better clinical identification of visceral pain conditions, the growth of hospital-based pain management services, and the presence of diverse drug classes.

The visceral pain market is projected to see significant expansion over the next few years, reaching $19.6 billion in 2030 with a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is attributed to the increasing demand for tailored pain therapies, a heightened focus on managing chronic pain, the broader application of precision medicine approaches, the growing adoption of advanced diagnostic tools, and rising investments in the development of non-opioid drugs. Important trends expected in the forecast period include the wider acceptance of targeted pain management therapies, an increased use of multimodal drug combinations, a greater emphasis on non-opioid treatment options, the expansion of personalized visceral pain management, and a stronger focus on early diagnosis and intervention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

What Drivers Are Expected To Influence The Visceral Pain Market During The Forecast Period?

The increasing need for pain-relieving medications is anticipated to propel the expansion of the visceral pain market in the coming years. Analgesics are drugs designed to alleviate pain by reducing or blocking the brain’s processing of pain signals. These medications help manage visceral pain through their action on the nervous system, modulating pain impulses that originate from internal organs. For instance, in April 2024, information from the New England Journal of Medicine, a UK-based weekly medical journal, revealed that over 53,600 clinicians were prescribing buprenorphine by December 2023. This marks an increment of 11,500 prescribers compared to December 2022. Thus, the growing demand for analgesics is a significant factor contributing to the development of the visceral pain market.

How Is The Visceral Pain Market Segmented Across Key Categories?

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Which Market Trends Are Creating New Opportunities In The Visceral Pain Market?

Leading firms in the chronic pain market are prioritizing clinical trials to create advanced solutions like NOP receptor agonists, aiming to deliver effective pain management with a potential reduction in risks linked to opioid therapies. These NOP receptor agonists are substances that stimulate the nociceptin/orphanin FQ peptide receptor, influencing pain signals within the nervous system. Their function is to alleviate chronic and visceral pain, circumventing the significant addiction potential or severe adverse reactions commonly seen with conventional opioids. An example is Grünenthal GmbH, a pharmaceutical company based in Germany, which commenced a Phase I first-in-human clinical trial in October 2024. This study involved 90 healthy participants to assess the safety, tolerability, and pharmacokinetics of their new NOP receptor agonist. The objective of this particular study is to determine the investigational compound’s capacity to deliver potent and safe pain alleviation for various chronic pain conditions, thereby presenting an innovative treatment strategy for both somatic and visceral pain.

Who Are The Dominant Players Shaping The Visceral Pain Market Landscape?

Major companies operating in the visceral pain market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Read the full visceral pain market report here:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

Which Region Is Forecast To Lead The Visceral Pain Market In Terms Of Market Size?

North America was the largest region in the visceral pain market in 2025. The regions covered in the visceral pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Visceral Pain Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp

Browse Through More Reports Similar to the Global Visceral Pain Market 2026, By The Business Research Company

Chronic Pain Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Neuropathic Pain Global Market Report

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Ulcerative Colitis Global Market Report

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795